Although there was no difference in the case-control analyses for GIPR
Glu354Gln for cardiometabolic group, regarding C allele carriers there were central nervous system (6).
69
Several GIP receptor polymorphisms have been described. These patients from a Dutch population (11). Genetic variations of the GIPR were not 78 associated with childhood obesity; nevertheless, a potential role in glucose 79 homeostasis was described for the GIPR SNP Glu354Gln (12).
80
Our preliminary results involving cardiometabolic risk factors has pointed 
Material and methods

88
Human subjects and blood samples collection questionnaire that had been formulated, tested and applied in our previous 141 study.
142
The sampling process was random, seeking criteria that would serve a 
Results
163
In this study 311 Brazilian participants were selected. The mean ages (Table 2) .
209
The family history for diseases (DM2, AH, dyslipidemia and obesity) had number of associations (Fig 3) . Regarding GIPR Glu354Gln, C allele carriers were twice as likely to 234 present the diagnosis of arterial hypertension and dyslipidemia (Fig 4) . cardiometabolic traits, we demonstrated for the first time that such a genetic
253
GIPR variant has a strong association with hypertension.
254
In the present work the distribution of genotypes for the GIPR Glu354Gln adolescents from Berlin, 6% of obese subjects had a polymorphic genotype,
267
18% have heterozygous genotype and 61% had a wild genotype (12).
268
Our study demonstrates the association of the GIPR Glu354Gln 
